| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |